Profilaggrin, an insoluble precursor of the intermediate filament-associated protein filaggrin, contains multiple internal repeats (PIRs). At terminal differentiation of epidermis, proteolytic processing within a ``linker'' region of each PIR releases soluble filaggrin in a two-stage process. The first stage endoproteinase (PEP1, profilaggrin endoproteinase 1) cleaves mouse profilaggrin at a subset of the linkers, yielding processing intermediates consisting of several filaggrin repeats. An epidermal endoproteinase that cleaves the requisite linker subset has been purified 4,966-fold from mouse epidermal extracts. SDS-polyacrylamide gel electrophoresis demonstrated a band of molecular mass of 29.5 kDa that correlated with the activity. Labeling with [H]diisopropylfluorophosphate identified PEP1 as a serine protease; inhibitor studies suggest that it is similar to chymotrypsin, as expected from previous in vivo studies. The purified PEP1 cleaved a peptide derived from profilaggrin (P1) at three residues within and adjacent to a multiple tyrosine sequence, consistent with the in vivo processing sites. No exopeptidase activity was detected. PEP1 is only active toward insoluble profilaggrin, resulting in partial solubilization, consistent with a role in dispersal of profilaggrin during terminal differentiation. In contrast to the specific cleavage of mouse profilaggrin, PEP1 cleaved all linker regions of rat profilaggrin. Studies with phosphorylated P1 suggest that PEP1 specificity may be partly regulated by profilaggrin phosphorylation.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Kamata, A. Taniguchi, M. Yamamoto, J. Nomura, K. Ishihara, H. Takahara, T. Hibino, and A. Takeda Neutral Cysteine Protease Bleomycin Hydrolase Is Essential for the Breakdown of Deiminated Filaggrin into Amino Acids J. Biol. Chem., May 8, 2009; 284(19): 12829 - 12836. [Abstract] [Full Text] [PDF]

				A. Sandilands, C. Sutherland, A. D. Irvine, and W. H. I. McLean Filaggrin in the frontline: role in skin barrier function and disease J. Cell Sci., May 1, 2009; 122(9): 1285 - 1294. [Abstract] [Full Text] [PDF]

				S. Netzel-Arnett, B. M. Currie, R. Szabo, C.-Y. Lin, L.-M. Chen, K. X. Chai, T. M. Antalis, T. H. Bugge, and K. List Evidence for a Matriptase-Prostasin Proteolytic Cascade Regulating Terminal Epidermal Differentiation J. Biol. Chem., November 3, 2006; 281(44): 32941 - 32945. [Abstract] [Full Text] [PDF]

				C. Leyvraz, R.-P. Charles, I. Rubera, M. Guitard, S. Rotman, B. Breiden, K. Sandhoff, and E. Hummler The epidermal barrier function is dependent on the serine protease CAP1/Prss8 J. Cell Biol., August 1, 2005; 170(3): 487 - 496. [Abstract] [Full Text] [PDF]

				D. R. Hewett, A. L. Simons, N. E. Mangan, H. E. Jolin, S. M. Green, P. G. Fallon, and A. N.J. McKenzie Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome Hum. Mol. Genet., January 15, 2005; 14(2): 335 - 346. [Abstract] [Full Text] [PDF]

				K. List, R. Szabo, P. W. Wertz, J. Segre, C. C. Haudenschild, S.-Y. Kim, and T. H. Bugge Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1 J. Cell Biol., November 24, 2003; 163(4): 901 - 910. [Abstract] [Full Text] [PDF]

				R. B. Presland and B. A. Dale Epithelial Structural Proteins of the Skin and Oral Cavity: Function in Health and Disease Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(4): 383 - 408. [Abstract] [Full Text] [PDF]